文献速递神经免疫

体重指数而非维生素D状态与多发性硬化脑体积变化相关

Body mass index, but not vitamin D status, is associated with brain volume change in MS.
PubMed 文献 · Neurology · 2018-11-14

在加利福尼亚大学旧金山分校的纵向多发性硬化队列中,469例临床孤立综合征或复发缓解型多发性硬化患者每年接受临床评估、脑MRI和抽血。多变量重复测量分析显示,体重指数每增加1 kg/m²与 normalized gray matter volume 减少1.1 mL及 normalized brain parenchymal volume 减少1.1 mL独立相关,而25-羟基维生素D水平与脑体积无显著关联。

要点

  • 体重指数每增加1 kg/m²与 normalized gray matter volume 减少1.1 mL独立相关。
  • 体重指数每增加1 kg/m²与 normalized brain parenchymal volume 减少1.1 mL独立相关。
  • 25-羟基维生素D水平与脑体积 measures 无显著关联。

核心结论

  • 较高的体重指数似乎与 normalized gray matter volume 和 normalized brain parenchymal volume 更大幅度的减少相关;normalized gray matter volume 丢失预示更长期的残疾。
  • 由于肥胖可干预,作者认为应进一步详细探索这些关系,并可能有必要评估降低体重指数对多发性硬化影像和临床结局的影响。

研究设计与样本

  • 表达、蛋白质组学、影像、临床(EPIC)是加利福尼亚大学旧金山分校的纵向多发性硬化队列研究。
  • 纳入基线时为临床孤立综合征或复发缓解型多发性硬化的患者,每年进行临床评估、脑MRI和抽血。
  • 共469名参与者;采用多变量重复测量分析,调整年龄、性别、种族、吸烟状态和多发性硬化治疗使用。

主要发现

  • 在469名参与者中,体重指数每增加1 kg/m²与 normalized gray matter volume 减少1.1 mL独立相关(95% CI -1.8 至 -0.5,p=0.001)。
  • 体重指数与 normalized brain parenchymal volume 独立相关:体重指数每增加1 kg/m²,normalized brain parenchymal volume 减少1.1 mL(95% CI -2.1 至 -0.05,p=0.039)。
  • 维生素D水平与脑体积 measures 无显著关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether body mass index (BMI) or vitamin D status is associated with MRI measures of neurodegeneration in a cohort of individuals with relapsing-remitting multiple sclerosis (RRMS) or clinically isolated syndrome (CIS). METHODS: Expression, Proteomics, Imaging, Clinical (EPIC) is a longitudinal multiple sclerosis (MS) cohort study at the University of California, San Francisco. Participants had clinical evaluations, brain MRI, and blood draws annually. We evaluated patients with CIS or RRMS at baseline. In multivariate repeated-measures analyses adjusted for age, sex, ethnicity, smoking status, and use of MS treatments, annual 25-hydroxyvitamin D levels and BMI were evaluated for their association with subsequent brain volumes (normalized gray matter [nGMV], brain parenchymal [nBPV], and white matter volumes, as determined by Structural Image Evaluation using Normalization of Atrophy-X). RESULTS: Among 469 participants, each 1-kg/m2 higher BMI was independently associated with reduced nGMV in multivariate models (-1.1 mL, 95% confidence interval [CI] -1.8 to -0.5, p = 0.001). BMI was likewise independently associated with nBPV (nBPV per 1-kg/m2 greater BMI: -1.1 mL, 95% CI -2.1 to -0.05, p = 0.039). Vitamin D levels did not appear to be meaningfully associated with brain volumes. CONCLUSIONS: Higher BMI appears to be associated with greater reductions in nGMV and nBPV, which is relevant because, in particular, nGMV loss portends greater longer-term disability. Because obesity is modifiable, further studies should explore these relationships in detail, and evaluating the effect of reducing BMI on imaging and clinical outcomes in MS may be warranted.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Mowry EM, Azevedo CJ, McCulloch CE, et al. Body mass index, but not vitamin D status, is associated with brain volume change in MS. Neurology. 2018. PMID: 30429274. doi:10.1212/WNL.0000000000006644

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。